Journal article
Targeting STAT3 in gastric cancer
AS Giraud, TR Menheniott, LM Judd
Expert Opinion on Therapeutic Targets | TAYLOR & FRANCIS LTD | Published : 2012
Abstract
Introduction: STAT3 is a key transcription factor for many regulatory factors that modulate gene transcription. Particularly important are cytokines and growth factors that maintain homeostasis by regulating immunocytes, stromal and epithelial cells. Dysregulation of STAT3 by constitutive activation plays an important role in the initiation of inflammation and cellular transformation in numerous cancers, especially of epithelial origin. This review focuses on STAT3 drive in gastric cancer initiation and progression, with emphasis on its activation by cytokines, and how targeting the primary drivers or gastric STAT3 therapeutically may prevent or slow stomach cancer development. Areas covered..
View full abstractGrants
Funding Acknowledgements
Supported by NHMRC (Australia) and the Victorian Government's Operational Infrastructure Support Program.